Israel takes a risk on tomorrow’s epic drugs
FutuRx, a partnership between OrbiMed, J&J and Takeda Ventures, is one of three new government-backed, high-risk pharma incubators in Israel.
FutuRx, a partnership between OrbiMed, J&J and Takeda Ventures, is one of three new government-backed, high-risk pharma incubators in Israel.
“A key aim of Johnson & Johnson Innovation is to find novel ways of advancing the most promising early-stage science.”